Skip to main content

Mintz's Role on Biolog-id SPAC included in 'Deal Watch'

Mintz's representation of digital health solution provider Biolog-id was mentioned in The American Lawyer's 'Deal Watch'. The article summarized the deal, "Mintz is serving as legal advisor to Biolog-id, a digital health solution provider focusing on value-chain optimization, in its agreement to become a publicly-traded company via a business combination with Genesis Growth Tech Acquisition Corp., a special purpose acquisition company, with an implied equity value of $312 million for Biolog-id... After the transaction closes, which is expected to take place in the first quarter of 2023, the combined company is expected to list on the Nasdaq under the ticker symbol “BGID.”


The American Lawyer